R-ICE regimen

View Patient Information

A regimen consisting of rituximab, ifosfamide, carboplatin and etoposide that can be used for the treatment of nodular lymphocyte-predominant Hodgkin lymphoma and certain forms of non-Hodgkin lymphoma (NHL), such as Burkitt lymphoma and diffuse large B-cell lymphoma.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	ICE plus rituximab ifosfamide/carboplatin/etoposide/rituximab RICE regimen rituximab-ifosfamide-carboplatin-etoposide regimen rituximab/ifosfamide/carboplatin/etoposide rituximab/ifosfamide/carboplatin/etoposide regimen

R-ICE regimen

Search NCI's Drug Dictionary